Results for tag: "Cytokine Release Syndrome Drug"

The Cytokine Release Syndrome Drug market is a subset of the Immune Disorders Drugs market. It is composed of drugs used to treat the symptoms of Cytokine Release Syndrome (CRS), a condition caused by an overactive immune response. CRS is a potentially life-threatening condition that can occur as a result of certain treatments, such as cancer immunotherapy. The drugs used to treat CRS are typically monoclonal antibodies, which are designed to target and block the action of specific cytokines. The Cytokine Release Syndrome Drug market is a rapidly growing sector of the Immune Disorders Drugs market, driven by the increasing prevalence of CRS and the development of new treatments. Companies in the market include Roche, Novartis, Merck, and Bristol-Myers Squibb. These companies are actively researching and developing new drugs to treat CRS, as well as other immune disorders. Show Less Read more